Cargando...
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition
Despite recent advances in the treatment of chronic lymphocytic leukemia (CLL) with chemoimmunotherapy, many CLL patients are older or frail and cannot tolerate aggressive chemotherapy. Even those who can inevitably develop resistance due to factors such as deletion of pro-apoptotic factors like TP5...
Gardado en:
| Publicado en: | Leuk Lymphoma |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557771/ https://ncbi.nlm.nih.gov/pubmed/23614795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.796051 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|